{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:56:11Z","timestamp":1776290171310,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013822","name":"Kurdistan University Of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-02832-z","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:37:33Z","timestamp":1747906653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Memory function in patients with opioid dependence treated with buprenorphine and methadone in comparison with healthy persons"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-7625","authenticated-orcid":false,"given":"Sara Kamali","family":"Ardakani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1792-2522","authenticated-orcid":false,"given":"Sara","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0860-8040","authenticated-orcid":false,"given":"Khaled","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-3367","authenticated-orcid":false,"given":"Narges","family":"Shamsalizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2832_CR1","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","volume":"394","author":"L Degenhardt","year":"2019","unstructured":"Degenhardt, L. et al. Global patterns of opioid use and dependence: Harms to populations, interventions, and future action. Lancet 394, 1560\u20131579 (2019).","journal-title":"Lancet"},{"key":"2832_CR2","doi-asserted-by":"publisher","first-page":"100341","DOI":"10.1016\/j.lanepe.2022.100341","volume":"16","author":"G Castelpietra","year":"2022","unstructured":"Castelpietra, G. et al. The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990\u20132019: Findings from the global burden of disease study 2019. Lancet Reg. Health Eur 16, 100341 (2022).","journal-title":"Lancet Reg. Health Eur"},{"key":"2832_CR3","doi-asserted-by":"publisher","first-page":"e0116820","DOI":"10.1371\/journal.pone.0116820","volume":"10","author":"HA Whiteford","year":"2015","unstructured":"Whiteford, H. A. et al. The global burden of mental, neurological and substance use disorders: An analysis from the global burden of disease study 2010. PloS One. 10, e0116820 (2015).","journal-title":"PloS One"},{"key":"2832_CR4","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.3390\/molecules28134969","volume":"28","author":"DM Ciuc\u0103 Anghel","year":"2023","unstructured":"Ciuc\u0103 Anghel, D. M. et al. Understanding the mechanisms of action and effects of drugs of abuse. Molecules 28, 4969 (2023).","journal-title":"Molecules"},{"key":"2832_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2021.0976","volume":"78","author":"T Santo","year":"2021","unstructured":"Santo, T. et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: A systematic review and meta-analysis. JAMA Psychiatry. 78, 979\u2013993 (2021).","journal-title":"JAMA Psychiatry"},{"key":"2832_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ADM.0000000000000457","volume":"13","author":"MA Coe","year":"2019","unstructured":"Coe, M. A., Lofwall, M. R. & Walsh, S. L. Buprenorphine Pharmacology review: Update on transmucosal and long-acting formulations. J. Addict. Med. 13, 93\u2013103 (2019).","journal-title":"J. Addict. Med."},{"key":"2832_CR7","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.4103\/IJPC.IJPC_180_17","volume":"24","author":"M Sunilkumar","year":"2018","unstructured":"Sunilkumar, M. & Lockman, K. Practical pharmacology of methadone: A long-acting opioid. Indian J. Palliat. Care. 24, S10 (2018).","journal-title":"Indian J. Palliat. Care"},{"key":"2832_CR8","doi-asserted-by":"publisher","first-page":"129552","DOI":"10.52965\/001c.129552","volume":"13","author":"P Brown","year":"2025","unstructured":"Brown, P. et al. Methadone for chronic pain: A review of pharmacology, efficacy, and safety concerns. Health Psychol. Res. 13, 129552 (2025).","journal-title":"Health Psychol. Res."},{"key":"2832_CR9","first-page":"342","volume":"104","author":"J Bonhomme","year":"2012","unstructured":"Bonhomme, J. et al. Opioid addiction and abuse in primary care practice: A comparison of methadone and buprenorphine as treatment options. J. Natl. Med. Assoc. 104, 342\u2013350 (2012).","journal-title":"J. Natl. Med. Assoc."},{"key":"2832_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/0976-3147.91934","volume":"3","author":"PJ Whelan","year":"2012","unstructured":"Whelan, P. J. & Remski, K. Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds. J. Neurosci. Rural Pract. 3, 45\u201350 (2012).","journal-title":"J. Neurosci. Rural Pract."},{"key":"2832_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-11-13","volume":"11","author":"P Rapeli","year":"2011","unstructured":"Rapeli, P. et al. Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: Stability and correlates. BMC Clin. Pharmacol. 11, 1\u201316 (2011).","journal-title":"BMC Clin. Pharmacol."},{"key":"2832_CR12","first-page":"109","volume":"7","author":"S Mazhari","year":"2015","unstructured":"Mazhari, S. et al. Assessment of cognitive functions in methadone maintenance patients. Addict. Health. 7, 109 (2015).","journal-title":"Addict. Health"},{"key":"2832_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt, L. et al. Buprenorphine versus methadone for the treatment of opioid dependence: A systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 10, 386\u2013402 (2023).","journal-title":"Lancet Psychiatry"},{"key":"2832_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1874941000801010005","volume":"1","author":"S Giacomuzzi","year":"2008","unstructured":"Giacomuzzi, S. et al. Buprenorphine-and methadone maintenance treatment: Influence on aspects of cognitive and memory performance. Open Addict. J 1, 5 (2008).","journal-title":"Open Addict. J"},{"key":"2832_CR15","first-page":"57","volume":"6","author":"O Saed","year":"2008","unstructured":"Saed, O., Rushan, R. & Moradi, A. Investigating psychometric properties of Wechsler memory Scale-for the students of Tehran universities. Clin. Psychol. Pers. 6, 57\u201370 (2008).","journal-title":"Clin. Psychol. Pers."},{"key":"2832_CR16","first-page":"56","volume":"7","author":"M Orangi","year":"2002","unstructured":"Orangi, M., Atef, V. M. & Ashayeri, H. Standardization of the revised Wechsler memory scale in Shiraz. IJPCP. 7, 56\u201366 (2002).","journal-title":". IJPCP"},{"key":"2832_CR17","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/09084282.2012.689267","volume":"20","author":"P Kent","year":"2013","unstructured":"Kent, P. The evolution of the Wechsler memory scale: A selective review. Appl. Neuropsychol. Adult. 20, 277\u2013291 (2013).","journal-title":"Appl. Neuropsychol. Adult"},{"key":"2832_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/JCP.0b013e31818a6d38","volume":"28","author":"M Soyka","year":"2008","unstructured":"Soyka, M. et al. Cognitive functioning during methadone and buprenorphine treatment: Results of a randomized clinical trial. J. Clin. Psychopharmacol. 28, 699\u2013703 (2008).","journal-title":"J. Clin. Psychopharmacol."},{"key":"2832_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jocn.2022.04.018","volume":"101","author":"M Arezoomandan","year":"2022","unstructured":"Arezoomandan, M. et al. Inflammatory, oxidative stress and cognitive functions in patients under maintenance treatment with methadone or buprenorphine and healthy subjects. J. Clin. Neurosci. 101, 57\u201362 (2022).","journal-title":"J. Clin. Neurosci."},{"key":"2832_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6904-7-5","volume":"7","author":"P Rapeli","year":"2007","unstructured":"Rapeli, P. et al. Methadone vs. buprenorphine\/naloxone during early opioid substitution treatment: A naturalistic comparison of cognitive performance relative to healthy controls. BMC Clin. Pharmacol. 7, 1\u201310 (2007).","journal-title":"BMC Clin. Pharmacol."},{"key":"2832_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1037\/1064-1297.14.2.157","volume":"14","author":"SA Gruber","year":"2006","unstructured":"Gruber, S. A. et al. Methadone maintenance improves cognitive performance after two months of treatment. Exp. Clin. Psychopharmacol. 14, 157 (2006).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"2832_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s002130000628","volume":"154","author":"HV Curran","year":"2001","unstructured":"Curran, H. V. et al. Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study. Psychopharmacology 154, 153\u2013160 (2001).","journal-title":"Psychopharmacology"},{"key":"2832_CR23","doi-asserted-by":"publisher","first-page":"102603","DOI":"10.1016\/j.ajp.2021.102603","volume":"58","author":"NS Nikraftar","year":"2021","unstructured":"Nikraftar, N. S. et al. Comparison of psychological symptoms and cognitive functions in patients under maintenance treatment with methadone or buprenorphine, current opioid users and healthy subjects. Asian J. Psychiatr. 58, 102603 (2021).","journal-title":"Asian J. Psychiatr"},{"key":"2832_CR24","doi-asserted-by":"publisher","first-page":"102181","DOI":"10.1016\/j.ajp.2020.102181","volume":"53","author":"R Saroj","year":"2020","unstructured":"Saroj, R. et al. Neurocognitive functions in patients on buprenorphine maintenance for opioid dependence: A comparative study with three matched control groups. Asian J. Psychiatr. 53, 102181 (2020).","journal-title":"Asian J. Psychiatr"},{"key":"2832_CR25","doi-asserted-by":"publisher","first-page":"19662","DOI":"10.1038\/srep19662","volume":"6","author":"W Li","year":"2016","unstructured":"Li, W. et al. Methadone-induced damage to white matter integrity in methadone maintenance patients: A longitudinal self-control DTI study. Sci. Rep. 6, 19662 (2016).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02832-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T09:37:35Z","timestamp":1747906655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-02832-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2832"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-02832-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17780"}}